Skip to main content
Fig. 3. | Cancer Imaging

Fig. 3.

From: The use of advanced imaging in guiding the further investigation and treatment of primary prostate cancer

Fig. 3.

78-year-old man presents with PSA 15.90 ng/mL and PSA density 0.14 ng/mL2 for PET-targeted HIFU of a PI-RADS 5 lesion in the right posterior apex. Pre-therapy 68 Ga-PSMA11 A and 68 Ga-RM2 C axial PET, axial fused PET/MRI, MRI, and MIP images show concordant focal uptake in the right posterior prostate (red arrows). After HIFU, 68 Ga-PSMA11 B and 68 Ga-RM2 D axial PET, axial fused PET/MRI, MRI, and MIP show structural changes with urine pooling in the treated area (blue arrows) but no pathologic uptake. Biopsy confirmed no evidence of PC in the treated area

Back to article page